A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma
Sia, Hanlon, Tan, Peter T., Richter, Joshua, Ho, Phoebe Joy, Cochrane, Tara, Quach, Hang, Dhakal, Binod, Proscurshim, Igor, Jiang, Tony, Mancino, Emaryn, Salhi, Yacine, Stefano, Sammicheli, Gudi, Girish, Garton, Andrew, Feldman, Eric J., Spencer, Andrew
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Final Safety and Efficacy Results from the CPX-351 Early Access Program (EAP) for Older Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML)
Roboz, Gail J., Larson, Melissa L., Rubenstein, S. Eric, Solomon, Scott R, Schiller, Gary J., An, Qi, Mancino, Emaryn, Chiarella, Michael, Louie, Arthur C., Lin, Tara L
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article